ChemSpider 2D Image | 2-Phenyl-1,3-propanediyl dicarbamate hydrate (1:1) | C11H16N2O5

2-Phenyl-1,3-propanediyl dicarbamate hydrate (1:1)

  • Molecular FormulaC11H16N2O5
  • Average mass256.255 Da
  • Monoisotopic mass256.105927 Da
  • ChemSpider ID21395752

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1,3-Propanediol, 2-phenyl-, dicarbamate, hydrate (1:1) [ACD/Index Name]
2-Phenyl-1,3-propandiyldicarbamathydrat (1:1) [German] [ACD/IUPAC Name]
2-Phenyl-1,3-propanediyl dicarbamate hydrate (1:1) [ACD/IUPAC Name]
Dicarbamate de 2-phényl-1,3-propanediyle, hydrate (1:1) [French] [ACD/IUPAC Name]
[1177501-39-1] [RN]
1177501-39-1 [RN]
2-Phenylpropane-1,3-diyl dicarbamate hydrate
3-(CARBAMOYLOXY)-2-PHENYLPROPYL CARBAMATE HYDRATE
Felbamate (hydrate)
Felbamate hydrate
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      Felbamate hydrate (FBM) is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate (NMDA) . MedChem Express
      Felbamate hydrate (FBM) is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate (NMDA) .; Target: NMDA Receptor; Felbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. MedChem Express HY-B0184A
      Felbamate hydrate (FBM) is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate (NMDA) .;Target: NMDA ReceptorFelbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy.Felbamate has been proposed to a unique dual mechanism of action as a positive modulator of GABAA receptors and as a blocker of NMDA receptors, particularly isoforms containing the NR2B subunit. Although it is clear that felbamate does cause pharmacological inhibition of NMDA receptor of relevance of NMDA receptor blockade as a strategy for the treatment of human epilepsy has been quest MedChem Express HY-B0184A
      Membrane Tranporter/Ion Channel MedChem Express HY-B0184A
      Membrane Tranporter/Ion Channel; Neuronal Signaling; MedChem Express HY-B0184A
      NMDA Receptor MedChem Express HY-B0184A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement